Related Experiment Video
Updated: May 10, 2026

A Screening Method for Identification of Heterochromatin-Promoting Drugs Using Drosophila
Published on: March 12, 2020
Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth
Xiaoyu Hu1, Pranabananda Dutta, Amy Tsurumi
1Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY 14642, USA.
Abstract:
Tumor suppressors known to date impede cancer growth by arresting the cell cycle or promoting apoptosis. Here we show that unphosphorylated human STAT5A functions as a tumor suppressor capable of repressing multiple oncogenes via heterochromatin formation. Unphosphorylated STAT5A binds to heterochromatin protein 1α (HP1α) and stabilizes heterochromatin. Expressing unphosphorylated STAT5A or HP1α inhibits colon cancer growth in mouse xenograft models. Transcriptome profiling shows that expressing an unphosphorylatable STAT5A has similar effects to overexpressing HP1α in global gene expression. Notably, the majority of the genes commonly repressed by unphosphorylated STAT5A and HP1α have been implicated in cancer development. Finally, down-regulation, somatic mutations, and deletions of STAT5 genes are found in certain human cancers. These results suggest that unphosphorylated STAT5A may epigenetically suppress tumor growth by promoting heterochromatin formation.
Insights
Unphosphorylated STAT5A acts as a novel tumor suppressor by forming heterochromatin to repress oncogenes. This epigenetic mechanism inhibits colon cancer growth and is disrupted in human cancers.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Traditional tumor suppressors halt cancer by cell cycle arrest or apoptosis.
- The role of STAT5A in tumor suppression, particularly its unphosphorylated form, remains largely unexplored.
Purpose of the Study:
- To investigate the function of unphosphorylated STAT5A as a tumor suppressor.
- To elucidate the mechanism by which unphosphorylated STAT5A represses oncogenes.
- To assess the therapeutic potential of unphosphorylated STAT5A and HP1α in cancer models.
Main Methods:
- Investigated the interaction between unphosphorylated STAT5A and heterochromatin protein 1α (HP1α).
- Utilized mouse xenograft models to evaluate the impact of unphosphorylated STAT5A and HP1α on colon cancer growth.
- Performed transcriptome profiling to analyze gene expression changes induced by unphosphorylated STAT5A.
Main Results:
- Unphosphorylated STAT5A functions as a tumor suppressor by forming heterochromatin and repressing oncogenes.
- Unphosphorylated STAT5A binds to and stabilizes heterochromatin protein 1α (HP1α).
- Expression of unphosphorylated STAT5A or HP1α significantly inhibited colon cancer growth in vivo.
- Genes commonly repressed by unphosphorylated STAT5A and HP1α are frequently implicated in cancer development.
- Down-regulation, mutations, and deletions of STAT5 genes were observed in human cancers.
Conclusions:
- Unphosphorylated STAT5A epigenetically suppresses tumor growth through heterochromatin formation.
- STAT5A and HP1α represent potential therapeutic targets for cancer treatment.
- Disruption of STAT5 genes contributes to the development of certain human cancers.
Related Concept Videos
Abnormal Proliferation
The JAK-STAT Signaling Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
